- Home
- ASTH vs BLFS Comparison
ASTH vs BLFS Comparison
Compare ASTH & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTH
- BLFS
- Stock Information
- Founded
- ASTH 1994
- BLFS 1987
- Country
- ASTH United States
- BLFS United States
- Employees
- ASTH N/A
- BLFS N/A
- Industry
- ASTH Professional Services
- BLFS Medical/Dental Instruments
- Sector
- ASTH Consumer Discretionary
- BLFS Health Care
- Exchange
- ASTH Nasdaq
- BLFS Nasdaq
- Market Cap
- ASTH 1.3B
- BLFS 1.2B
- IPO Year
- ASTH N/A
- BLFS 1989
- Fundamental
- Price
- ASTH $30.11
- BLFS $26.31
- Analyst Decision
- ASTH Strong Buy
- BLFS Strong Buy
- Analyst Count
- ASTH 8
- BLFS 7
- Target Price
- ASTH $53.29
- BLFS $30.86
- AVG Volume (30 Days)
- ASTH 328.6K
- BLFS 356.3K
- Earning Date
- ASTH 11-06-2025
- BLFS 11-11-2025
- Dividend Yield
- ASTH N/A
- BLFS N/A
- EPS Growth
- ASTH N/A
- BLFS N/A
- EPS
- ASTH 0.52
- BLFS N/A
- Revenue
- ASTH $2,419,115,000.00
- BLFS $93,468,000.00
- Revenue This Year
- ASTH $60.92
- BLFS $26.07
- Revenue Next Year
- ASTH $27.52
- BLFS $16.86
- P/E Ratio
- ASTH $57.97
- BLFS N/A
- Revenue Growth
- ASTH 51.97
- BLFS 68.16
- 52 Week Low
- ASTH $21.20
- BLFS $19.10
- 52 Week High
- ASTH $63.20
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- ASTH 56.62
- BLFS 57.56
- Support Level
- ASTH $27.64
- BLFS $24.33
- Resistance Level
- ASTH $29.88
- BLFS $27.42
- Average True Range (ATR)
- ASTH 1.35
- BLFS 0.89
- MACD
- ASTH 0.04
- BLFS 0.08
- Stochastic Oscillator
- ASTH 85.54
- BLFS 70.51
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.